In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Meet the trialist - DAPA-HF

Event : ESC Congress 2019

Topic : European Society of Cardiology - Other

  • Session type : Late-Breaking Science
  • Date : 02 September 2019
  • Time : 08:00 - 08:30

1 presentation in this session

DAPA HF - The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial

Event : ESC Congress 2019

  • Session : Meet the trialist - DAPA-HF
  • Speaker : JJV McMurray (Glasgow,GB)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are